Skip to search formSkip to main contentSkip to account menu

Symbicort

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Objective To observe the efficacy of aerosol inhalation of tiotropium and symbicort on FeNO, total IgE in serum, inflammatory… 
2017
2017
Ramadan, the 9 th month of Islamic calendar ranging for 29-30 days in duration, during which Muslims are fasting . It was… 
2016
2016
Background Cystic fibrosis (CF) is a chronic, life-limiting disease caused by mutations in the CF transmembrane conductance… 
2014
2014
Background: Recently, higher efficacy of the combination of long-acting beta2-adrenoceptor agonist and inhaled corticosteroids on… 
2013
2013
Objective To observe the therapeutic effectiveness of symbicort turbuhaler plus montelukast on moderate and severe bronchial… 
2012
2012
Objective To observe the therapeutic effect and safety of Budesonide and Formoterol Fumarate inhalation(Symbicort Turbuhaler) in… 
Review
2008
Review
2008
  • D. Halpin
  • Journal of Medical Economics
  • 2008
  • Corpus ID: 13205367
Abstract Objective: This systematic review examines the published evidence on the pharmacoecomonics of Symbicort®*. Symbicort is… 
2005
2005
Objective:  The use of combination inhaled corticosteroid/long‐acting β‐agonist therapy within the framework of a self‐management… 
Review
2002
Review
2002
  • J. Kips
  • Pulmonary Pharmacology & Therapeutics
  • 2002
  • Corpus ID: 24486330
Asthma varies in severity over time; consequently, treatment regimens must be sufficiently flexible to be adjusted when necessary…